Global Blood Plasma Market Report: 2015 Edition – New Report by Koncept Analytics

DELHI, India - July 14, 2015 - PRLog -- Albumin has been a key driver of the plasma market over the last two years for two key reasons. Firstly, strong demand from China, at nearly a 100% price premium over European prices, and secondly, security warnings in Europe related to solutions containing hydroxethyl starches (HES), one of the indications of albumin. For this reason, for some plasma players like CSL and Grifols, albumin grew at double-digit rates in 2013 and also posted a strong performance in 2014.

As immunoglobulin (IG) is used for a wide range of indications, most of them chronic, thus its volume growth is likely to remain solid. Off-label use accounts for 75% of the uses of IG in the US, for example, as doctors prescribe IG when there is evidence of a cure, even if a certain indication is not approved. It is the most profitable of the plasma proteins, due its high prices (lower product availability in each liter of plasma) and significant penetration in profitable markets.

As per the research report, “Global Blood PlasmaMarket: 2015 Edition” prospects for the market continue to see value up by mid-single digit each year except plasma-derived FVIII, due to intense competition from recombinants and pricing pressure. All major players in this industry are increasing capacity to meet future demands of blood plasma product. The market’s main growth driver include new indications for existing proteins, new products, emerging market growth, better diagnosis, efforts from plasma companies to educate doctors, an ageing population as well as weight or inclusion of plasma products in healthcare systems.

The report by Koncept Analytics provides a critical analysis and rational insight of the global blood plasma market. The major segments of the market are also discussed in detail in the report. The report also encompasses growth drivers of the blood plasma industry coupled with recent trends and challenges being faced by the industry.In the end, the report prudently provides business overviewof major players of this industry along with their key financials and business strategies.

List of Charts

Plasma Extraction from Donated Blood (Recovered Plasma)
Plasmapheresis (Sourced Plasma)
Global Blood Plasma Market Value (2010-2014E)
Global Blood Plasma Market by Product Type (2014E)
Global Immunoglobulin Market Value (2013-2018E)
The US Immunoglobulin Market Value (2013-2018E)
Global Immunoglobulin Market Volume (2010-2014E)
Global Immunoglobulin Market Volume Share by Region (2014E)
Global Market Volume for IVIG (2010-2020E)
Global Albumin Market Value (2013-2018E)
Global Albumin Market Volume (2012-2020E)
Global Albumin Market Volume Share by Region (2014E)
Global Factor VIII Market Value (2013-2018E)
Global Plasmatic FVIII Market Volume Share by Region (2014E)
Global A1PI Market (2013-2018E)
The US Plasma Collections (2010-2014E)
Global Health Care Expenditure Per Capita (2009-2014E)
Global Ageing Population Over 65 (2009-2014E)
Global Male Population (2010-2014)
Capacity Expansion by Major Commercial Fractionators
Global Blood Plasma Market Share by Company (2014)
Plasma Collection Market Share by Company (2014)
Global Immunoglobulin Market Share by Company (2014)
Immunoglobulin Sales by Company (2010-2014)
The US Immunoglobulin Market by Company (2014E)
Global Albumin Market Share by Company (2014E)
Global Plasma-Derived Factor VIII Market Share by Company (2014E)
Global A1PI Market Share by Company (2014E)
Baxter's Revenue Share by Segments (2014)
Baxter's Net Sales and Net Income (2010-2014)
Grifols's Net Revenue by Division (2014)
Grifols’s Net Revenue by Region (2014)
Grifols’s Net Revenue and Net Profit (2010-2014)
CSL Group’s Sales by Major Products (2014)
CSL Group’s Sales by Region (2014)
CSL Group’s Total Revenue and Net Profit (2010-2014)
CSL's R&D Investment (2010-2014)
Octapharma's Revenue and Net Profit (2010-2014)
Global Blood Plasma Market Forecast (2013-2018F)

List of Tables

Constituents of Blood Plasma
Recovered plasma vs. Sourced plasma
Output per Liter of Plasma
Main Plasma Products
Global Immunoglobulin Market Share by Therapeutic Area
FVIII (Plasmatic + Recombinant) Usage Comparison (2014)
IVIG Usage Comparison (2014)
Low Diagnosis Rate in Diseases Treated With Immunoglobulin
Immunoglobulin Market Pricing Power
Recombinant Factor VIII Pipeline
Potential Threats to Immunoglobulin Market
Differentiation Among The Big Three
Global Plasma Market Position (2014E)
Medicare Reimbursement Rates by Company & Product
Immunoglobulin: Positioning of Top Players
Dependent & Independent Variables (2010-2014)
Correlation Matrix
Model Summary - Coefficient of Determination
Regression Coefficients Output

Note:  Purchase by Section Also Available

For more Information:

http://www.konceptanalytics.com/Researchreport/global-blood-plasma-market-report-2015-edition-212.aspx

Koncept Analytics

Vikas Gupta

(Business Development Manager)

FFCS-36, Ansal Plaza

Vaishali, Ghaziabad

U.P - 201010

Tele: +91-120-4130959

Mobile: +91-9811715635

Mail ID – vikas@konceptanalytics.com

Koncept Analytics is a market research company. We are in the field of Market Research from last 10 Years. We do research in telecommunication, healthcare, pharmaceutical, financial services, energy, technology, real estate, logistics, food & beverages and media sectors. For more information:

http://www.konceptanalytics.com